OPINION
ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application ("ANDA") by defendant Actavis Elizabeth LLC ("Actavis") seeking to market a generic sublingual tablet containing buprenorphine and naloxone. Plaintiffs Orexo AB and Orexo US. Inc. (collectively "Orexo...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.